Advertisement

Laser Photodynamic Therapy of Xenotransplanted Human Renal Cell Carcinoma

  • S. Pomer
  • G. Graschew
  • H. Sinn
  • T. Kälble
  • G. Staehler
Conference paper

Abstract

Photodynamic therapy (PDT) has recently attracted much attention, especially among urologists, because it appears to be a selective form of cancer treatment which causes minimal damage to surrounding normal tissues. In particular, the multifocal bladder carcinoma in situ, up to now difficult to detect endoscopically, has become a new domain for the integral laser photodynamic therapy [1–3].

Keywords

Renal Cell Carcinoma Photodynamic Therapy Partial Nephrectomy Renal Capsule Human Renal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Benson RC (1985) Treatment of diffuse transitional cell carcinoma in situ by whole bladder haematoporphyrin derivative photodynamic therapy. J Urol 134: 675–678PubMedGoogle Scholar
  2. 2.
    Jocham DS, Staehler G, Chaussy C, Hammer C, Lohrs U (1981) Laserbehandlung von Blasentumoren nach Photosensibilisierung mit Haematoporphyrin-Derivat. Urologe [A] 20: 340–345Google Scholar
  3. 3.
    Staehler G, Colombo M (1990) Laser ablation in urology. Lasers Med Sci 5: 203–207CrossRefGoogle Scholar
  4. 4.
    Marberger M (1986) Conservative surgery for renal adenocarcinoma. In: de Kernion JB, Pavone-Macaluso M (eds) Tumors of the kidney. Williams and Wilkins, BaltimoreGoogle Scholar
  5. 5.
    Novick AC, Streem S, Montie JE, Pontes JE, Siegel S, Montague DK, Goormastic U (1989) Conservative surgery for renal cell carcinoma. A single-center experience with 100 patients. J Urol 141: 835PubMedGoogle Scholar
  6. 6.
    Morgan WR, Zincke H (1990) Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended follow up. J Urol 144: 852–858PubMedGoogle Scholar
  7. 7.
    Lipson RL, Blades EJ (1960) The photodynamic properties of a particular haematoporphyrin derivative. Arch Dermatol 82: 508–512PubMedGoogle Scholar
  8. 8.
    Sinn H, Schrenk HH, Friedrich EA, Schilling U, Maier-Borse W (1990) Design of a compound having an enhanced tumor uptake using serum albumin as a carrier, part I. Nucl Med Biol 17: 819–827Google Scholar
  9. 9.
    Bogden AE, Hasbell PM, Lepage DJ (1979) Growth of human xenografts implanted under the renal capsule of normal mice. Exp Cell Biol 17: 819–827Google Scholar
  10. 10.
    Graschev G, Shopova M, Anastassova G, Chakarova A, Getov C (1988) Sensitivity of individual tumors to photodynamic therapy. Lasers Med Sci 3: 233–238CrossRefGoogle Scholar
  11. 11.
    Smith RB (1986) The treatment of bilateral renal cell carcinoma or renal cell carcinoma in the solitary kidney. In: de Kernion JB, Pavone-Macaluso M (eds) Tumors of the kidney. Williams and Wilkins, BaltimoreGoogle Scholar
  12. 12.
    Jacobs SC, Berg S, Lawson RK (1980) Synchronous bilateral renal cell carcinoma; total surgical excision. Cancer 46: 234CrossRefGoogle Scholar
  13. 13.
    Stöckle M, Störkel S, Mielke R, Steinbach F, Gallen E, Riedmiller H, Hohenfellner R (1990) Charakterisierung konservativ behandelter Nierenzellcarcinome. Aktuel UrolGoogle Scholar
  14. 14.
    Rosenthal CL, Kraft R, Zingg EJ (1984) Organ preserving surgery in renal cell carcinoma Tumor enucleation versus partial kidney resection. Eur Urol 10: 222–230PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • S. Pomer
    • 1
  • G. Graschew
    • 2
  • H. Sinn
    • 2
  • T. Kälble
    • 1
  • G. Staehler
    • 1
  1. 1.Abteilung UrologieChirurgische UniversitätsklinikHeidelbergGermany
  2. 2.Deutsches KrebsforschungszentrumHeidelbergGermany

Personalised recommendations